caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1609809524

Michelle HeckerMD

PRACTICEMETROHEALTHSee all providers at this practice →
Infectious DiseaseCleveland, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
307
Beneficiaries
—
Total drug cost
$100K
Distinct drugs
14
Brand share
53.1%
Top prescribed drugs
Methenamine Hippurate58 claims
Nitrofurantoin Monohyd/M-Cryst45 claims
Ciprofloxacin Hcl24 claims
Sulfamethoxazole/Trimethoprim22 claims
Estrogens, Conjugated22 claims
REFERRAL NETWORK

Where Michelle Hecker's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
James Kennen
Diagnostic Radiology · Cleveland, OH
1138
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
48
Unique beneficiaries
—
Total services
72
Distinct HCPCS
3
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 241 Infectious Disease providers in OH — bottom quintile (cohort median 426).